ChoA Pharmaceutical Co., LTD. (KOSDAQ: 034940)
South Korea
· Delayed Price · Currency is KRW 955.00
-48.00 (-4.79%)
Dec 19, 2024, 9:00 AM KST
ChoA Pharmaceutical Co., LTD. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -13,072 | -10,514 | 560.69 | -8,044 | -1,319 | -905.31 | Upgrade
|
| Depreciation & Amortization | 2,476 | 2,387 | 2,388 | 2,893 | 3,050 | 2,811 | Upgrade
|
| Loss (Gain) From Sale of Assets | -297.77 | -85.73 | - | -8.72 | -3.77 | -62.54 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1,989 | 1,989 | 107.1 | 1,938 | 946.19 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -46.24 | -171.99 | -235.85 | -1,605 | -737.7 | -202.11 | Upgrade
|
| Loss (Gain) on Equity Investments | -18.4 | -19.87 | 4.83 | -17.96 | -11.2 | -10.7 | Upgrade
|
| Provision & Write-off of Bad Debts | -50 | 202.2 | -230.01 | 269.87 | 109.57 | 529.15 | Upgrade
|
| Other Operating Activities | 4,696 | 4,384 | 1,864 | 3,899 | 2,809 | 3,506 | Upgrade
|
| Change in Accounts Receivable | 2,332 | 2,287 | -2,644 | 400.47 | 2,363 | -378.33 | Upgrade
|
| Change in Inventory | -673.73 | -2,212 | -549.25 | 2,292 | -3,455 | 144.87 | Upgrade
|
| Change in Accounts Payable | -947.3 | 507.62 | 1,304 | 81.5 | 79.75 | 1,061 | Upgrade
|
| Change in Other Net Operating Assets | -1,171 | -228.1 | -4,012 | -3,580 | -1,909 | -2,336 | Upgrade
|
| Operating Cash Flow | -4,784 | -1,475 | -1,443 | -1,480 | 1,922 | 4,157 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -53.77% | 103.33% | Upgrade
|
| Capital Expenditures | -706.94 | -831.13 | -2,782 | -3,544 | -3,598 | -1,389 | Upgrade
|
| Sale of Property, Plant & Equipment | 485.56 | 128.61 | - | 14.55 | 3.77 | 266.39 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -359.58 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -134.68 | -111.52 | -140.19 | -319.99 | -42.39 | -272.4 | Upgrade
|
| Investment in Securities | 379.16 | 1,944 | 1,479 | 1,566 | 29.79 | -865.69 | Upgrade
|
| Other Investing Activities | -507.34 | -398.94 | -110.22 | 417.53 | -70.15 | -109.77 | Upgrade
|
| Investing Cash Flow | -484.24 | 731.38 | -1,553 | -1,866 | -4,037 | -2,371 | Upgrade
|
| Long-Term Debt Issued | - | 15,349 | 7,658 | 9,344 | 1,000 | - | Upgrade
|
| Long-Term Debt Repaid | - | -17,012 | -5,863 | -4,621 | -4,664 | -1,890 | Upgrade
|
| Net Debt Issued (Repaid) | 6,269 | -1,662 | 1,795 | 4,723 | -3,664 | -1,890 | Upgrade
|
| Other Financing Activities | -35.22 | -27.22 | 11.51 | 101.29 | -168.02 | -202 | Upgrade
|
| Financing Cash Flow | 6,234 | -1,690 | 1,807 | 4,825 | -3,832 | -2,092 | Upgrade
|
| Foreign Exchange Rate Adjustments | -69.6 | -44.95 | -33.84 | 106.45 | 73.71 | 206.07 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - | Upgrade
|
| Net Cash Flow | 896.67 | -2,478 | -1,223 | 1,585 | -5,873 | -100.11 | Upgrade
|
| Free Cash Flow | -5,490 | -2,306 | -4,225 | -5,024 | -1,677 | 2,768 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 3737.74% | Upgrade
|
| Free Cash Flow Margin | -8.93% | -3.66% | -6.13% | -8.73% | -2.57% | 4.10% | Upgrade
|
| Free Cash Flow Per Share | -177.27 | -74.45 | -136.37 | -162.17 | -54.12 | 97.76 | Upgrade
|
| Cash Interest Paid | 974.17 | 913.95 | 564.55 | 287.07 | 203.18 | 267.67 | Upgrade
|
| Cash Income Tax Paid | 11.02 | -10.98 | -45.22 | - | 46.92 | 141.35 | Upgrade
|
| Levered Free Cash Flow | -2,102 | -850.27 | -3,337 | -3,096 | -1,623 | 1,693 | Upgrade
|
| Unlevered Free Cash Flow | -1,445 | -238.19 | -2,914 | -2,861 | -1,241 | 2,562 | Upgrade
|
| Change in Net Working Capital | -3,975 | -3,813 | 2,079 | -2,486 | -509.54 | -1,668 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.